Clinical trials for Cancer in United States

Saruparib (AZD5305) vs Placebo in Men With Metastatic Castration-Sensitive Prostate Cancer Receiving Physician's Choice New Hormonal Agents

Study ID: NCT06120491

Sponsor

AstraZeneca

Orca-T Following Chemotherapy and Total Marrow and Lymphoid Irradiation for the Treatment of Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia or Myelodysplastic Syndrome

Study ID: NCT06195891

Sponsor

City of Hope Medical Center

Prospective Collection of Samples to Enable the Development of Natera Screening Assay for Early Cancer Detection

Study ID: NCT06620627

Sponsor

NATA, Inc.

BOLD-100 in Combination With FOLFOX for the Treatment of Advanced Solid Tumours

Study ID: NCT04421820

Sponsor

Bold Therapeutics, Inc.

A First-in-human Dose Escalation and Expansion Study to Evaluate the Safety, and Tolerability of AZD8421 Alone or in Combination in Participants With Selected Advanced or Metastatic Solid Tumors

Study ID: NCT06188520

Sponsor

AstraZeneca

Study of D3S-002 as Monotherapy in Adult Subjects With Advanced Solid Tumors With MAPK Pathway Mutations

Study ID: NCT05886920

Sponsor

D3 Bio (Wuxi) Co., Ltd

Registry to Collect Health Information About Desmoplastic Small Round Cell Tumor

Study ID: NCT04690374

Sponsor

Memorial Sloan Kettering Cancer Center

Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)

Study ID: NCT06393374

Sponsor

Merck Sharp & Dohme LLC

ID Of Prognostic Factors In Mycosis Fungoides/Sezary Syndrome

Study ID: NCT02848274

Sponsor

Stanford University

Utilization of Educational Interventions in Completion of Genetic Testing in Black Patients with High-Risk Prostate Cancer

Study ID: NCT05958082

Sponsor

Henry Ford Health System